A type <scp>IV</scp> Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis

Published:2022-07-14 Issue:9 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Booijink Richell¹²,Salgado‐Polo Fernando²,Jamieson Craig³,Perrakis Anastassis²^ORCID,Bansal Ruchi¹^ORCID

Affiliation:

1. Translational Liver Research, Department of Medical Cell BioPhysics, Faculty of Science and Technology University of Twente Enschede The Netherlands

2. Oncode Institute, Division of Biochemistry Netherlands Cancer Institute Amsterdam The Netherlands

3. Department of Pure and Applied Chemistry University of Strathclyde Glasgow UK

Funder

Oncode Institute

Techmed Centre, University of Twente

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202216333

Reference62 articles.

1. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12

2. Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C

3. From NASH to HCC: current concepts and future challenges

4. Burden of liver diseases in the world

5. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of an Autotaxin Inhibitor, 2-(4-Chlorophenyl)-7-methyl-8-pentylimidazo[1,2-a] Pyrimidin-5(8H)-one (CBT-295), on Bile Duct Ligation-Induced Chronic Liver Disease and Associated Hepatic Encephalopathy in Rats;ACS Pharmacology & Translational Science;2024-08-13

2. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies;Chinese Journal of Natural Medicines;2024-08

3. ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis;Liver International;2024-03-22

4. Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease;Lipids in Health and Disease;2024-02-17

5. Marginal Maternal Zinc Deficiency Produces Liver Damage and Altered Zinc Transporter Expression in Offspring Male Rats;Biological Trace Element Research;2023-09-01